Process for the preparation of intermediates useful in the preparation of Hepatitis C virus (HCV) inhibitors
Abstract:
The present invention generally relates to a process for preparation of 9-halo-3-(2-haloacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one of Formula I, which is an intermediate in the preparation of Hepatitis C Virus (HCV) inhibitors.
Information query
Patent Agency Ranking
0/0